UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
28.78
-0.90 (-3.03%)
At close: May 15, 2026, 4:00 PM EDT
28.40
-0.38 (-1.32%)
Pre-market: May 18, 2026, 5:01 AM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.4 billion as of May 18, 2026. Its market cap has increased by 166.63% in one year.
Market Cap
1.40B
Enterprise Value
1.46B
1-Year Change
166.63%
Ranking
Category
Stock Price
$28.78
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.40B, an increase of 670.87%. That is a compound annual growth rate of 25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.40B | 27.90% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.49B |
| Damora Therapeutics | 1.48B |
| Vir Biotechnology | 1.48B |
| AtaiBeckley | 1.47B |
| Immatics | 1.46B |
| Immunocore Holdings | 1.43B |
| KalVista Pharmaceuticals | 1.42B |
| Maze Therapeutics | 1.41B |